• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Sotatercept Coming Soon

January 10, 2023 By Dr. Jeremy Feldman

stimulant drugs associated with pulmonary arterial hypertension

A new drug is poised to enter the PAH market and offers great promise for patients. This new drug works in a completely different way from all the currently approved medications. Sotatercept is an injection (shot) that is given subcutaneously (under the skin) every 3 weeks. The medication acts by blocking activin. In PAH there are good signals and bad signals within the blood … [Read more...]

Aerovate and Inhaled Imatinib

February 13, 2022 By Dr. Jeremy Feldman

Imatinib is a tyrosine kinase inhibitor that has been on the market for more than 20 years to treat a type of leukemia.  It acts by turning off tyrosine kinases.   You can think of tyrosine kinases as critical switches in cells that turn on and off critical pathways.  Too much of an “on” signal leads to dysregulated cell proliferation and growth—such as seen … [Read more...]

Sotatercept for Pulmonary Arterial Hypertension

February 3, 2022 By Dr. Jeremy Feldman

For the past 30 years, all our pulmonary arterial hypertension medications were described as vasodilators:   First prostanoids (epoprostenol), then endothelin receptor antagonists (bosentan, ambrisentan, macitentan) and PDE5 inhibitors (sildenafil and tadalafil).  These medications work through different mechanism but all lead to the vasodilation or … [Read more...]

Pulmonary Hypertension and Interstitial Lung Disease

October 27, 2020 By Dr. Jeremy Feldman

pulmonary hypertension related lung disease

Pulmonary hypertension (elevated pressure within the blood vessels of the lungs) is organized into five groups: Group 1:  Pulmonary arterial hypertension (PAH) Group 2:  Pulmonary venous hypertension (due to problems on the left side of the heart) Group 3:  Pulmonary hypertension due to lung disease Group 4:  Pulmonary hypertension due … [Read more...]

Lung Transplantation with PAH

October 6, 2020 By Dr. Jeremy Feldman

lungs PAH

For Pulmonary Arterial Hypertension (PAH) patients who remain very short of breath despite maximal medical therapy, lung transplantation may be an option.  Maximal medical therapy usually means continuously infused therapy (Remodulin, Flolan, Veletri) and multiple oral medications.  First, it is important to know that lung transplantation is not a … [Read more...]

Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Caregiver excercise

Exercise and Pulmonary Arterial Hypertension

By Dr. Jeremy Feldman

A common question that I am asked by patients is how much activity can they safely perform.  What type of exercise is

PH Support Group

Flu Vaccine in Young Adults with Congenital Heart Disease and Pulmonary Hypertension

By Dr. Jeremy Feldman

By Tabitha Moe and Jeremy Feldman As a young adult with congenital heart disease, it is important for you to take

good news in pah

 

Disclaimer

Recent Blog Posts

  • Sotatercept Coming Soon January 10, 2023
  • Why Abortion Matters to PAH Patients May 3, 2022
  • Aerovate and Inhaled Imatinib February 13, 2022

Categories

Archives